| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $219K | -40.5% |
| Cost of Revenue | $136K | -74.7% |
| R&D Expense | $12.5M | +10.7% |
| SG&A Expense | $13.3M | +16.7% |
| Operating Income | -$25.7M | -12.5% |
| Pre-tax Income | -$23.5M | +19.8% |
| Net Income | -$23.5M | +19.8% |
| EPS (Basic) | -$5.17 | +99.8% |
| EPS (Diluted) | -$5.17 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $990K | -95.8% |
| Short-term Investments | $33.7M | — |
| Accounts Receivable | $1.5M | +26.3% |
| Inventory | $2.0M | +1257.6% |
| Current Assets | $39.8M | +55.7% |
| Total Assets | $50.1M | +66.3% |
| Current Liabilities | $4.8M | +37.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | -148.3% |
| Capital Expenditures | $1.2M | +17.0% |
| Investing Cash Flow | -$34.1M | -1262.9% |
| Financing Cash Flow | $35.1M | +32.0% |
| Free Cash Flow | -$24.8M | -135.3% |
| +99.8% |
| Total Liabilities |
| $11.3M |
| -38.9% |
| Stockholders' Equity | $38.8M | +234.3% |